Alison Ritchie

2.0k total citations · 2 hit papers
42 papers, 1.6k citations indexed

About

Alison Ritchie is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Alison Ritchie has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Genetics. Recurrent topics in Alison Ritchie's work include Estrogen and related hormone effects (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Alison Ritchie is often cited by papers focused on Estrogen and related hormone effects (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Alison Ritchie collaborates with scholars based in United Kingdom, United States and Australia. Alison Ritchie's co-authors include Morwenna Muir, Jeffrey L. Cummings, Peter J. Sadler, Robert E. Morris, Duncan I. Jodrell, Rhona Aird, Simon P. Langdon, William R. Miller, John F. Smyth and Peter Mullen and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Small.

In The Last Decade

Alison Ritchie

42 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

2002 532 citations Rhona Aird, Jeffrey L. Cummings et al. British Journal of Cancer profile →
Does age matter? The impact of rodent age on study outcomes

2016 249 citations Alison Ritchie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Ritchie United Kingdom	20	699	655	483	158	124	42	1.6k
Manon Carré France	27	675 1.0×	1.1k 1.7×	349 0.7×	76 0.5×	278 2.2×	65	2.3k
Hans den Dulk Netherlands	24	838 1.2×	919 1.4×	631 1.3×	65 0.4×	95 0.8×	57	2.0k
Jayden A. Smith United Kingdom	22	514 0.7×	811 1.2×	366 0.8×	74 0.5×	92 0.7×	36	1.4k
Jürgen Engel Germany	23	223 0.3×	914 1.4×	408 0.8×	95 0.6×	74 0.6×	57	1.8k
Sonia Zorzet Italy	33	1.6k 2.2×	1.1k 1.7×	1.1k 2.2×	58 0.4×	241 1.9×	103	3.5k
Joe W. Ramos United States	27	536 0.8×	1.8k 2.7×	298 0.6×	119 0.8×	283 2.3×	67	2.7k
Wei Fan China	25	234 0.3×	691 1.1×	276 0.6×	59 0.4×	152 1.2×	105	1.7k
Marcella Coronnello Italy	22	786 1.1×	696 1.1×	504 1.0×	26 0.2×	60 0.5×	44	1.6k
Chunhao Yang China	29	290 0.4×	745 1.1×	1.4k 2.8×	63 0.4×	95 0.8×	136	2.4k
Lynne A. Jones United States	27	419 0.6×	1.1k 1.7×	203 0.4×	267 1.7×	212 1.7×	71	2.3k

Countries citing papers authored by Alison Ritchie

Since Specialization

Citations

This map shows the geographic impact of Alison Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Ritchie more than expected).

Fields of papers citing papers by Alison Ritchie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Ritchie. The network helps show where Alison Ritchie may publish in the future.

Co-authorship network of co-authors of Alison Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Ritchie. A scholar is included among the top collaborators of Alison Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Ritchie. Alison Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ashworth, J., Alison Ritchie, Nigel P. Mongan, et al.. (2024). The role of mesenchymal cells in cholangiocarcinoma. Disease Models & Mechanisms. 17(12). 2 indexed citations

Mathieu, C., Carole Mura, Anna M. Grabowska, et al.. (2023). Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects. Small. 19(12). e2205961–e2205961. 3 indexed citations

Cavanagh, Robert, Asmaa Ibrahim, Amanda K. Pearce, et al.. (2023). Chain-extension in hyperbranched polymers alters tissue distribution and cytotoxicity profiles in orthotopic models of triple negative breast cancers. Biomaterials Science. 11(19). 6545–6560. 1 indexed citations

Jones, S J, et al.. (2023). Application of a 3D hydrogel-based model to replace use of animals for passaging patient-derived xenografts. PubMed. 2(3-4). 99–111. 5 indexed citations

Ali, Reem, Alison Ritchie, Katia A. Mesquita, et al.. (2023). Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. International Journal of Molecular Sciences. 24(13). 10966–10966. 2 indexed citations

Fletcher, Nicholas L., Robert Cavanagh, Zachary H. Houston, et al.. (2022). Synthesis, characterisation and evaluation of hyperbranched N-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo. Biomaterials Science. 10(9). 2328–2344. 5 indexed citations

Ashworth, J., S J Jones, Alison Ritchie, et al.. (2020). A 3D Heterotypic Breast Cancer Model Demonstrates a Role for Mesenchymal Stem Cells in Driving a Proliferative and Invasive Phenotype. Cancers. 12(8). 2290–2290. 13 indexed citations

Pearce, Amanda K., Robert Cavanagh, Patricia Monteiro, et al.. (2020). Effects of Polymer 3D Architecture, Size, and Chemistry on Biological Transport and Drug Delivery In Vitro and in Orthotopic Triple Negative Breast Cancer Models. Advanced Healthcare Materials. 9(22). e2000892–e2000892. 21 indexed citations

Taresco, Vincenzo, Michael W. Fay, Alison Ritchie, et al.. (2020). Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours. European Journal of Pharmaceutics and Biopharmaceutics. 157. 108–120. 48 indexed citations

10.

Rahman, Cheryl V., Stuart Smith, Paul S. Morgan, et al.. (2013). Adjuvant Chemotherapy for Brain Tumors Delivered via a Novel Intra-Cavity Moldable Polymer Matrix. PLoS ONE. 8(10). e77435–e77435. 23 indexed citations

11.

Aird, Rhona, Jeffrey L. Cummings, Alison Ritchie, et al.. (2002). In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. British Journal of Cancer. 86(10). 1652–1657. 532 indexed citations breakdown →

12.

Arends, Mark J., et al.. (2000). Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer. The Breast. 9(2). 96–106. 13 indexed citations

13.

Spanswick, Victoria J., et al.. (1998). Pharmacological and Biochemical Determinants of the Antitumour Activity of the Indoloquinone EO9. Biochemical Pharmacology. 55(3). 253–260. 25 indexed citations

14.

Cameron, David, Alison Ritchie, Simon P. Langdon, Thomas Anderson, & William R. Miller. (1997). Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Research and Treatment. 45(2). 99–107. 44 indexed citations

15.

Jones, Daniel A., et al.. (1997). Processing of [d-Arg1,d-Phe5,d-Trp7,9,Leu11]Substance P in Xenograft Bearing Nu/Nu Mice. Peptides. 18(7). 1073–1077. 3 indexed citations

16.

Cummings, Jeffrey L., Simon P. Langdon, Alison Ritchie, et al.. (1996). Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice. Annals of Oncology. 7(3). 291–296. 17 indexed citations

17.

Bowman, Angela, et al.. (1995). Effect of Human Recombinant Interferon-α on the Activity of cis-Diamminedichloroplatinum(II) in Human Non-Small Cell Lung Cancer Xenografts. Cancer Investigation. 13(6). 595–603. 2 indexed citations

18.

Cummings, Jeffrey L., Daniel A. Jones, Simon P. Langdon, et al.. (1995). Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]-substance P (6—11) in nude mice bearing the H69 small-cell lung cancer xenograft. Annals of Oncology. 6(6). 595–602. 10 indexed citations

19.

Langdon, Simon P., A. Jayne Crew, Alison Ritchie, et al.. (1994). Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. European Journal of Cancer. 30(5). 682–686. 54 indexed citations

20.

Langdon, Simon P., Alison Ritchie, A. Jayne Crew, et al.. (1993). Contrasting effects of 17 β‐estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo. International Journal of Cancer. 55(3). 459–464. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact